Effect of docetaxel on metastatic tumor 18F-fluorocholine uptake in patients with hormone-refractory prostate cancer

被引：0
|
作者：
Kwee, Sandi [1 ]
Jiang, Caroline [2 ]
Lim, John [1 ]
Coel, Marc [1 ]
机构：
[1] Queens Med Ctr, Hamamatsu Queens PET Imaging Ctr, Honolulu, HI USA
[2] John A Burns Sch Med, Dept Med, Honolulu, HI USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2011年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1902
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Prognostic role of chromogranin A expression for docetaxel response in hormone-refractory metastatic prostate cancer
    Gernone, A.
    Trabucco, S.
    Troccoli, G.
    Pagliarulo, V.
    Pagliarulo, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [32] A systematic review of the effectiveness of docetaxel and mitoxantrone for the treatment of metastatic hormone-refractory prostate cancer
    R Collins
    R Trowman
    G Norman
    K Light
    A Birtle
    E Fenwick
    S Palmer
    R Riemsma
    British Journal of Cancer, 2006, 95 : 457 - 462
  • [33] Docetaxel, low-dose estramustine, and doxifluridine in hormone-refractory metastatic prostate cancer
    Wada, Yoshihiro
    Kikuchi, Ken
    Takahashi, Wataru
    Honda, Jiro
    Nakanishi, Juro
    Matsumoto, Koichiro
    Kuwahara, Tomohiro
    Kai, Nobuyuki
    Kikukawa, Hiroaki
    Ueda, Shoichi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (01) : 53 - 61
  • [34] Docetaxel, low-dose estramustine, and doxifluridine in hormone-refractory metastatic prostate cancer
    Yoshihiro Wada
    Ken Kikuchi
    Wataru Takahashi
    Jiro Honda
    Juro Nakanishi
    Koichiro Matsumoto
    Tomohiro Kuwahara
    Nobuyuki Kai
    Hiroaki Kikukawa
    Shoichi Ueda
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 53 - 61
  • [35] A systematic review of the effectiveness of docetaxel and mitoxantrone for the treatment of metastatic hormone-refractory prostate cancer
    Collins, R.
    Trowman, R.
    Norman, G.
    Light, K.
    Birtle, A.
    Fenwick, E.
    Palmer, S.
    Riemsma, R.
    BRITISH JOURNAL OF CANCER, 2006, 95 (04) : 457 - 462
  • [36] A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel
    Ross, Robert W.
    Beer, Tomasz M.
    Jacobus, Susanna
    Bubley, Glenn J.
    Taplin, Mary-Ellen
    Ryan, Christopher W.
    Huang, Jiaoti
    Oh, William K.
    CANCER, 2008, 112 (03) : 521 - 526
  • [37] 18F-fluorocholine for prostate cancer imaging: a systematic review of the literature
    G Bauman
    T Belhocine
    M Kovacs
    A Ward
    M Beheshti
    I Rachinsky
    Prostate Cancer and Prostatic Diseases, 2012, 15 : 45 - 55
  • [38] Thyroid 18F-fluorocholine uptake in patients with chronic autoimmune thyroiditis
    Ciappuccini, Renaud
    Saguet-Rysanek, Virginie
    Dorbeau, Marine
    Lequesne, Justine
    Linard, Camille
    Lefevre-Arbogast, Sophie
    Clarisse, Benedicte
    Bardet, Stephane
    EUROPEAN THYROID JOURNAL, 2022, 11 (03)
  • [39] A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer
    Goodin, S
    Rao, KV
    Kane, M
    Dave, N
    Capanna, T
    Doyle-Lindrud, S
    Engle, E
    Jin, LX
    Todd, M
    DiPaola, RS
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (02) : 199 - 204
  • [40] A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer
    Susan Goodin
    Kamakshi V. Rao
    Michael Kane
    Nisha Dave
    Terry Capanna
    Susan Doyle-Lindrud
    Elizabeth Engle
    Lixian Jin
    Mary Todd
    Robert S. DiPaola
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 199 - 204
12345